InvestorsHub Logo
Followers 20
Posts 936
Boards Moderated 0
Alias Born 04/02/2015

Re: None

Wednesday, 12/28/2022 2:23:32 PM

Wednesday, December 28, 2022 2:23:32 PM

Post# of 711654
All rGBM patients (n40) get DC vaccine

Half (n20) get neoadjuvant PD-1 inhibitor while the other half (n20) get adjuvant PD-1 inhibitor.

Preliminary 2yr survival results:
25% neoadjuvant
60% adjuvant

The rGBM DCVax-L P3 showed:
10% “standard of care”
20% DCVax-L
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News